Overview of (1->3)-beta-D-glucan immunobiology

By Williams David L.  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 247-250

Informa Healthcare

Access to resources Recommend Favorite

Pharm acokinetics, biological effects, and distribution of (1->3)-beta-D-glucan in blood and organs in rabbits

By Yoshida Minoru   Roth Robert I.   Grunfeld Carl   Feingold Kenneth R.   Levin Jack  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 279-283

Informa Healthcare

Access to resources Recommend Favorite

Investigations of the relationship betw een disease and airborne (1->3)-beta-D-glucan in buildings

By Rylander Ragnar  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 275-277

Informa Healthcare

Access to resources Recommend Favorite

Inhalation toxicity of (1->3)-beta-D glucan: recent advances

By Fogelmark Birgitta   Sjostrand Margareta   Williams David   Rylander Ragnar  

Mediators of Inflammation, Vol. 6, Iss. 4, 1997-11 ,pp. : 263-265

Informa Healthcare

Access to resources Recommend Favorite

What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?

By Metan Gökhan   Nedret Koç A.   Atalay Altay   Kaynar Leyla Gül   Ozturk Ahmet   Alp Emine   Eser Bülent  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 5, 2012-05 ,pp. : 330-336

Informa Healthcare

Access to resources Recommend Favorite